A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
- Status
- RECRUITING
- Phase
- N/A
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada
- Status
- COMPLETED
- Phase
- N/A
Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)
- Status
- COMPLETED
- Phase
- PHASE1
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
- Status
- RECRUITING
- Phase
- PHASE3
LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT
- Status
- UNKNOWN
- Phase
- N/A
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Abequolixron (RGX-104) and Durvalumab in Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Emulation of the KEYNOTE-189 Trial Using Electronic Health Records
- Status
- COMPLETED
- Phase
- N/A
The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC
- Status
- COMPLETED
- Phase
- NA
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
- Status
- RECRUITING
- Phase
- PHASE3
A Biomarker Screening Protocol for Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2